Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTERCEPTOR: Induction Chemo + Cetuximab vs Chemoradiation in HNC
NCT00999700Phase 3Unknown
- Sponsor
- Gruppo Oncologico Nord Ovest
- Start
- Sep 2009
- Primary completion
- Dec 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of KL-140 in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Gruppo Oncologico Nord Ovest. Status: unknown.
02
Drugs
KL-140
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00999700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00999700.